279 related articles for article (PubMed ID: 33007835)
21. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
[TBL] [Abstract][Full Text] [Related]
22. Targeting the A3 adenosine receptor for glaucoma treatment (review).
Fishman P; Cohen S; Bar-Yehuda S
Mol Med Rep; 2013 Jun; 7(6):1723-5. PubMed ID: 23563604
[TBL] [Abstract][Full Text] [Related]
23. Structural Characterization of Agonist Binding to an A
Stamatis D; Lagarias P; Barkan K; Vrontaki E; Ladds G; Kolocouris A
J Med Chem; 2019 Oct; 62(19):8831-8846. PubMed ID: 31502843
[TBL] [Abstract][Full Text] [Related]
24. Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo.
Butler M; Sanmugalingam D; Burton VJ; Wilson T; Pearson R; Watson RP; Smith P; Parkinson SJ
Eur J Immunol; 2012 Dec; 42(12):3358-68. PubMed ID: 23027555
[TBL] [Abstract][Full Text] [Related]
25. Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model.
Wang K; Peng B; Lin B
Glia; 2014 Dec; 62(12):1943-54. PubMed ID: 24989686
[TBL] [Abstract][Full Text] [Related]
26. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
[TBL] [Abstract][Full Text] [Related]
27. Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation.
Cueva Vargas JL; Osswald IK; Unsain N; Aurousseau MR; Barker PA; Bowie D; Di Polo A
J Neurosci; 2015 Sep; 35(35):12088-102. PubMed ID: 26338321
[TBL] [Abstract][Full Text] [Related]
28. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
[TBL] [Abstract][Full Text] [Related]
29. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma.
Naskar R; Wissing M; Thanos S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2962-8. PubMed ID: 12202516
[TBL] [Abstract][Full Text] [Related]
30. The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling.
Cueva Vargas JL; Belforte N; Di Polo A
Neurobiol Dis; 2016 Sep; 93():156-71. PubMed ID: 27163643
[TBL] [Abstract][Full Text] [Related]
31. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
[TBL] [Abstract][Full Text] [Related]
32. Identification of the A3 adenosine receptor in rat retinal ganglion cells.
Zhang M; Budak MT; Lu W; Khurana TS; Zhang X; Laties AM; Mitchell CH
Mol Vis; 2006 Aug; 12():937-48. PubMed ID: 16943766
[TBL] [Abstract][Full Text] [Related]
33. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
[TBL] [Abstract][Full Text] [Related]
34. Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia.
Galindo-Romero C; Valiente-Soriano FJ; Jiménez-López M; García-Ayuso D; Villegas-Pérez MP; Vidal-Sanz M; Agudo-Barriuso M
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):974-85. PubMed ID: 23307961
[TBL] [Abstract][Full Text] [Related]
35. Adenosine, adenosine receptors and glaucoma: an updated overview.
Zhong Y; Yang Z; Huang WC; Luo X
Biochim Biophys Acta; 2013 Apr; 1830(4):2882-90. PubMed ID: 23328492
[TBL] [Abstract][Full Text] [Related]
36. Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes.
Safran N; Shneyvays V; Balas N; Jacobson KA; Nawrath H; Shainberg A
Mol Cell Biochem; 2001 Jan; 217(1-2):143-52. PubMed ID: 11269659
[TBL] [Abstract][Full Text] [Related]
37. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
Thanos S; Naskar R
Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma.
Yang F; Wang D; Wu L; Li Y
Drug Des Devel Ther; 2015; 9():6095-107. PubMed ID: 26604697
[TBL] [Abstract][Full Text] [Related]
39. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
